as on January 27, 2026 at 4:01 pm IST
Day's Low
Day's High
3.21%
Downside
1.13%
Upside
52 Week's Low
52 Week's High
5.54%
Downside
46.45%
Upside
as on January 27, 2026 at 4:01 pm IST
Market Cap
₹6,748.27 Cr
Return on Equity (ROE)
13.15
PE Ratio (TTM)
20.7
Return on capital employed (ROCE)
10.7
Industry PE ratio
39.98
Beta (LTM)
1.27
P/B Ratio
3.15
Dividend Yield
0PEG Ratio
11.44
Quarterly Earnings Growth YOY
-35.93
EPS (TTM)
22.45
Sector
Pharmaceuticals
Book Value
199.01
Technical Analysis
Bearish
View Technical Analysis
as on January 27, 2026 at 4:01 pm IST
Akums Drugs in the last 5 years
Lowest (18.75x)
April 7, 2025
Today (20.70x)
January 27, 2026
Industry (39.98x)
January 27, 2026
Highest (66.86x)
August 19, 2024
Today’s Price to Earnings Ratio: 20.70x
Compare market cap, revenue, PE, and other key metrics of Akums Drugs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 6,748.27 | -9.23% | 0.53 | 343 | 4,118 | |
| NA | 3,476.83 | 81.48% | 0.00 | 183 | 653 | |
| NA | 12.37 | -7.44% | 0.00 | NA | 51 | |
| NA | 109.93 | -9.99% | 0.00 | 12 | 65 | |
| NA | 294.21 | 34.43% | 0.58 | 18 | 137 |
Based on 3 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Akums Drugs. Average target price of ₹646.67
Source: S&P Global Market Intelligence
Get share price movements and forecasts by analysts on Akums Drugs.
What analysts predicted
50.83%UPSIDE
Target Price
₹646.67
Current Price
₹428.75
Analyzed by
3 Analysts
High
₹730
Target
₹646.67
Low
₹600
Akums Drugs target price ₹646.67, a slight upside of 50.83% compared to current price of ₹428.75. According to 3 analysts rating.
Source: S&P Global Market Intelligence
Search interest for Akums Drugs & Pharmaceuticals Ltd Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:7% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Akums Drugs.
Akums Drugs & Pharmaceuticals Ltd’s net profit fell -37.46% since last year same period to ₹40.78Cr in the Q2 2025-2026. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated -35.76% fall in its net profits since last 3-months.
Read More about Earnings ResultsCheck stock indices that include Akums Drugs.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, AKUMS stock has moved up by 0.8%
MF Holding Up
![]()
Mutual Funds have increased holdings from 6.44% to 11.23% in Dec 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 75.26% of holdings in Dec 2025 quarter
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 2.28% to 1.15% in Dec 2025 quarter
Retail Holding Down
![]()
Retail Investor have decreased holdings from 10.46% to 6.46% in Dec 2025 quarter
| Organisation | Akums Drugs & Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Akums Drugs share price today stands at ₹428.75 as on at the close of the market. Akums Drugs share today touched a day high of ₹433.6 and a low of ₹415.
Akums Drugs touched a 52 week high of ₹627.9 and a 52 week low of ₹405. Akums Drugs share price today i.e. is closed at ₹428.75, which is -31.72% down from its 52 week high and 5.86% up from its 52 week low.
Akums Drugs market capitalisation is ₹6,748.27 Cr as on .
To buy Akums Drugs shares, you need to follow these steps:
Akums Drugs trading volume is 1.83L as on . This means that 1.83L shares of Akums Drugs were bought and sold on the stock market during today's trading session.